Physician

Jason Kent Lange, M.D.

According to 2025 Medicare claims, Jason Lange, M.D. (NPI: 1275593931) practices internal medicine in the Killeen-Temple, TX market, with the plurality of this provider's patient population coming from Bell, TX. This provider's primary affiliated billing organization is SCOTT & WHITE CLINIC (NPI: 1093779704; TIN: 742958277) and primary practice location at 76549-5721. Lange is affiliated with the Baylor Scott & White Quality Alliance (ACO ID: A2542), participating under the MSSP model.

Lange's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,577 traditional Medicare patients, billed 4,479 HCPCS/CPT codes, and received $156,336 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 4,201 prescription claims across 570 beneficiaries totaling $602,493 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 19 claims. Open Payments data shows 53 records totaling $1,155. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $137,903 to $602,493. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,681	4,129	$140,491
2016	1,831	4,821	$163,854
2017	1,726	4,626	$154,801
2018	1,806	4,961	$178,723
2019	1,760	5,033	$187,373
2020	1,598	4,971	$182,098
2021	1,596	4,830	$185,143
2022	1,576	4,673	$168,668
2023	1,754	4,924	$178,634
2024	1,577	4,479	$156,336

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	264	1,750	$137,903
2016	311	2,111	$191,306
2017	346	2,142	$215,089
2018	377	2,307	$230,924
2019	387	2,607	$276,686
2020	424	2,904	$350,876
2021	457	3,380	$424,681
2022	496	3,971	$489,401
2023	518	4,114	$561,127
2024	570	4,201	$602,493

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	20	$42,386
2021	N/R	19	$38,674
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	93	111	$125
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	140	188	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	403	613	$63
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	475	486	$47
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,387	1,999	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	168	10,836	$199,734
Xarelto	Rivaroxaban	125	7,650	$136,267
Entresto	Sacubitril/Valsartan	34	2,610	$55,529
Jardiance	Empagliflozin	31	2,370	$44,809
Repatha Sureclick	Evolocumab	52	2,198	$41,982

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	53	$1,155	Inari Medical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jason Kent Lange, M.D.?

Tedicare shows public-source Medicare data for Jason Kent Lange, M.D. (NPI 1275593931), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jason Kent Lange, M.D. have ACO affiliation data?

Jason Kent Lange, M.D. is shown with ACO affiliation data for Baylor Scott & White Quality Alliance (MSSP, ACO ID A2542).

What billing organization is linked to Jason Kent Lange, M.D.?

Jason Kent Lange, M.D. is linked to SCOTT & WHITE CLINIC (billing NPI 1093779704) in the available physician profile data.

Does Jason Kent Lange, M.D. have Open Payments data?

Jason Kent Lange, M.D. has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.